Vivera Pharmaceuticals is described as a non-addictive pain management company that also markets innovative testing and medical supply offerings. The company is expanding its PPE portfolio, including masks, gloves, and gowns, and aims to broaden distribution to hospitals, specialty care facilities, and medical distributors. Current plans include establishing a United States supply chain for testing and certified personal protective equipment. Vivera has partnered with Burkhan World to expand access and connect key suppliers and resources to its network. The company secured significant financial backing to support global growth and the purchase and distribution of medical supplies. Management emphasizes the role of reliable domestic supply chains in pandemic response and reopening communities.

Total raised

$440M

Funding rounds

1

Latest round

Equity

Latest activity

Dec 2020